Alliance Pharma PLC Director Share Dealing (1014H)
November 12 2018 - 9:51AM
UK Regulatory
TIDMAPH
RNS Number : 1014H
Alliance Pharma PLC
12 November 2018
12 November 2018
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Director Share Dealing
Alliance Pharma plc (AIM: APH), the international specialty
pharmaceutical group, announces that it was notified on 9 November
2018 that, on the same day, John Dawson, Non-Executive Director,
sold 1,100,000 ordinary shares of 1 pence each in the Company at a
price of 70.1 pence per share.
Following this transaction, Mr Dawson's total interest in the
Company is 55,476,402 ordinary shares, representing approximately
10.71 per cent of the Company's current issued share capital
(comprised of a total beneficial interest in 35,476,402 Ordinary
Shares, representing 6.85 per cent of the issued share capital, and
a total non-beneficial interest in 20,000,000 Ordinary Shares,
representing 3.86 per cent of the issued share capital).
For further information:
Alliance Pharma plc + 44 (0)1249 466966
Peter Butterfield, Chief Executive
Officer
Andrew Franklin, Chief Financial Officer
www.alliancepharma.co.uk
Buchanan + 44 (0)20 7466 5000
Mark Court / Sophie Wills / Gemma
Mostyn-Owen
Numis Securities Limited + 44 (0)20 7260 1000
Nominated Adviser: Michael Meade /
Freddie Barnfield
Corporate Broking: James Black
Investec Bank plc + 44 (0) 20 7597 5970
Corporate Finance: Daniel Adams /
Ed Thomas
Corporate Broking: Patrick Robb /
David Herring
The notification below, made in accordance with the requirements
of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by person
discharging managerial responsibilities and persons closely
associated with them.
1 Details of the person discharging managerial
responsibilities/person closely associated
a) Name Mr John Dawson
--------------------------- ------------------------------------
2 Reason for the notification
-----------------------------------------------------------------
a) Position/status Non-Executive Director
--------------------------- ------------------------------------
b) Initial notification Initial Notification
/Amendment
--------------------------- ------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
-----------------------------------------------------------------
a) Name Alliance Pharma plc
--------------------------- ------------------------------------
b) Legal Entity 213800RYIWZA4Q5WPZ13
Identifier
--------------------------- ------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and
(iv) each place where transactions have been
conducted
-----------------------------------------------------------------
a) Description Ordinary shares of 1.0 pence each
of the financial ISIN: GB0031030819
instrument,
type of instrument
Identification
code
--------------------------- ------------------------------------
b) Nature of the Sale of shares
transaction
--------------------------- ------------------------------------
c) Currency GBP
--------------------------- ------------------------------------
d) Price(s) and Price (p) Volume(s)
volume(s)
--------------------------- ------------------ ----------------
70.1p 1,100,000
-------------------------------- ------------------ ----------------
e) Aggregated 1,100,000 ordinary shares
information 70.1p
- Aggregated GBP770,720.01
volume
- Price
- Aggregated
total
--------------------------- ------------------------------------
f) Date of the 9 November 2018
transaction
--------------------------- ------------------------------------
g) Place of the London Stock Exchange, AIM
transaction
--------------------------- ------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHFKBDQPBDDFDD
(END) Dow Jones Newswires
November 12, 2018 10:51 ET (15:51 GMT)
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2024 to May 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From May 2023 to May 2024